Sydys Corp is a globally active biotechnology company developing immuno-oncology products.

Recent News:

17 MAY 2016 – Sydys Corp. Announces Publication of Phase 2b CVac™ Data Against Ovarian Cancer in Journal for ImmunoTherapy of Cancer

12 MAY 2016 – Prima Biomed Enters into Sale and Licensing Agreement with Sydys to Advance CVac™ Program